Polysaccharide-based nanoparticles: A versatile platform for drug delivery and biomedical imaging

Current Medicinal Chemistry

Volumn 19, Issue 19, 2012, Pages 3212-3219

  Saravanakumar, G ^a   Jo, D G ^a   Park, J H ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Chemical modification; Drug delivery; Imaging agents; Nanoparticles; Polysaccharides

Indexed keywords

CAMPTOTHECIN; CARBOXYMETHYLCELLULOSE; CD44V ANTIGEN; CHENODEOXYCHOLIC ACID; CHITOSAN; CHONDROITIN SULFATE; CISPLATIN; DEOXYCHOLIC ACID; DEXTRAN; DOCETAXEL; DOXORUBICIN; GOLD NANOPARTICLE; HEPARIN; INSULIN; MITOMYCIN C; NANOPARTICLE; NANOSPHERE; PACLITAXEL; POLYACRYLIC ACID; POLYCAPROLACTONE; POLYELECTROLYTE; POLYLACTIDE; POLYSACCHARIDE; POLYVINYL ALCOHOL; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRIPOLYPHOSPHATE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VASCULOTROPIN;

CANCER STAGING; CANCER THERAPY; CELL TYPE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COLLOID; CROSS LINKING; CYTOTOXICITY; DIAGNOSTIC IMAGING; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; ENDOCYTOSIS; EX VIVO STUDY; FLUORESCENCE IMAGING; HALF LIFE TIME; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PARTICLE SIZE; PATIENT COMPLIANCE; PHARMACODYNAMICS; PROTEIN EXPRESSION; REVIEW; TUMOR VOLUME; ZETA POTENTIAL;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; POLYSACCHARIDES;

EID: 84863698864     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800784658     Document Type: Review

References (145)

1. Allen, T.M.; Cullis, P.R. Drug delivery systems: entering the mainstream. Science, 2004, 303(5665), 1818-1822.
2. Langer, R. Drug delivery and targeting. Nature, 1998, 392(6679), 5-10.
3. Gregoriadis, G. Targeting of drugs. Nature, 1977, 265(5593), 407-411.
4. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov., 2003, 2(5), 347-360.
5. Park, J.H.; Lee, S.; Kim, J.H.; Park, K.; Kim, K.; Kwon, I.C. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci., 2008, 33(1), 113-137.
6. Haag, R.; Kratz, F. Polymer therapeutics: concepts and applications. Angew. Chem. Int. Ed., 2006, 45(8), 1198-1215.
7. Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechmol., 2007, 2(12), 751-760.
8. Davis, M.E.; Chen, Z.; Shin, D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov., 2008, 7(9), 771-782.
9. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the epr effect in macromolecular therapeutics: A review. J. Control. Release, 2000, 65(1-2), 271-284.
10. Allen, T.M. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer, 2002, 2(10), 750-763.
11. Hamidi, M.; Azadi, A.; Rafiei, P. Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev., 2008, 60(15), 1638-1649.
12. Schatz, C.; Louguet, S.; Le Meins, J.F.; Lecommandoux, S. Polysaccharide-block-polypeptide copolymer vesicles: towards synthetic viral capsids13. Angew. Chem. Int. Ed., 2009, 48(14), 2572-2575.
13. Liu, Y.; Sun, J.; Zhang, P.; He, Z. Amphiphilic polysaccharide- hydrophobicized graft polymeric micelles for drug delivery nanosystems. Curr. Med. Chem., 2011, 18(17), 2638-2648.
14. Liu, Z.; Jiao, Y.; Wang, Y.; Zhou, C.; Zhang, Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev., 2008, 60(15), 1650-1662.
15. Janes, K.A.; Calvo, P.; Alonso, M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev., 2001, 47(1), 83-97.
16. Park, K.; Kim, J.H.; Nam, Y.S.; Lee, S.; Nam, H.Y.; Kim, K.; Park, J.H.; Kim, I.S.; Choi, K.; Kim, S.Y.; Kwon, I.C. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J. Control. Release, 2007, 122(3), 305-314.
17. Makhlof, A.; Werle, M.; Tozuka, Y.; Takeuchi, H. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J. Control. Release, 2011, 149(1), 81-88.
18. Thanou, M.; Verhoef, J.C.; Junginger, H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev., 2001, 52(2), 117-126.
19. Schipper, N.G.M.; Olsson, S.; Hoogstraate, J.A.; deBoer, A.G.; Vårum, K.M.; Artursson, P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res., 1997, 14(7), 923-929.
20. Amidi, M.; Mastrobattista, E.; Jiskoot, W.; Hennink, W.E. Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev., 2010, 62(1), 59-82.
21. Amidi, M.; Romeijn, S.G.; Borchard, G.; Junginger, H.E.; Hennink, W.E.; Jiskoot, W. Preparation and characterization of protein-loaded n-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release, 2006, 111(1-2), 107-116.
22. Takeuchi, H.; Yamamoto, H.; Kawashima, Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev., 2001, 47(1), 39-54.
23. Platt, V.M.; Szoka, F.C. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or cd44, a hyaluronan receptor. Mol. Pharm., 2008, 5(4), 474-486.
24. Kaneo, Y.; Tanaka, T.; Nakano, T.; Yamaguchi, Y. Evidence for receptor-mediated hepatic uptake of pullulan in rats. J. Control. Release, 2001, 70(3), 365-373.
25. Alban, S.; Schauerte, A.; Franz, G. Anticoagulant sulfated polysaccharides: part i. Synthesis and structure-activity relationships of new pullulan sulfates. Carbohydr. Polym., 2002, 47(3), 267-276.
26. Leitner, V.M.; Walker, G.F.; Bernkop-Schnürch, A. Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm., 2003, 56(2), 207-214.
27. Mourya, V.K.; Inamdar, N.N. Chitosan-modifications and applications: opportunities galore. React. Funct. Polym., 2008, 68(6), 1013-1051.
28. Vercruysse, K.P.; Prestwich, G.D. Hyaluronate derivatives in drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 1998, 15(5), 513-555.
29. Nichifor, M.; Mocanu, G. In: Polysaccharides for Drug Delivery and Pharmaceutical Applications. Marchessault, R.H.; Ravenelle, F.; Zhu, X.X., Eds.; American Chemical Society: Washington, 2006; Vol. 934, pp. 289-303.
30. Kim, J.H.; Kim, Y.S.; Kim, S.; Park, J.H.; Kim, K.; Choi, K.; Chung, H.; Jeong, S.Y.; Park, R.W.; Kim, I.S.; Kwon, I.C. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control. Release, 2006, 111(1-2), 228-234.
31. Banerjee, T.; Mitra, S.; Kumar Singh, A.; Kumar Sharma, R.; Maitra, A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm., 2002, 243(1-2), 93-105.
32. Csaba, N.; Köping-Höggård, M.; Alonso, M.J. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm., 2009, 382(1-2), 205-214.
33. Bodnar, M.; Hartmann, J.F.; Borbely, J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules, 2005, 6(5), 2521-2527.
34. Janes, K.A.; Fresneau, M.P.; Marazuela, A.; Fabra, A.; Alonso, M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release, 2001, 73(2-3), 255-267.
35. Xu, Y.; Du, Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm., 2003, 250(1), 215-226.
36. Ahmad, Z.; Sharma, S.; Khuller, G.K. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis. Nanomedicine, 2007, 3(3), 239-243.
37. You, J.O.; Peng, C.A. Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol. Symp., 2005, 219(1), 147-153.
38. Hamman, J.H. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Mar Drugs, 2010, 8(4), 1305-1322.
39. Denuziere, A.; Ferrier, D.; Damour, O.; Domard, A. Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties. Biomaterials, 1998, 19(14), 1275-1285.
40. Cafaggi, S.; Russo, E.; Stefani, R.; Leardi, R.; Caviglioli, G.; Parodi, B.; Bignardi, G.; De Totero, D.; Aiello, C.; Viale, M. Preparation and evaluation of nanoparticles made of chitosan or n-trimethyl chitosan and a cisplatin-alginate complex. J. Control. Release, 2007, 121(1-2), 110-123.
41. Mao, S.; Bakowsky, U.; Jintapattanakit, A.; Kissel, T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J. Pharm. Sci., 2006, 95(5), 1035-1048.
42. Sarmento, B.; Ribeiro, A.; Veiga, F.; Sampaio, P.; Neufeld, R.; Ferreira, D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res., 2007, 24(12), 2198-2206.
43. Guang Liu, W.; De Yao, K. Chitosan and its derivatives-a promising non-viral vector for gene transfection. J. Control. Release, 2002, 83(1), 1-11.
44. Ishii, T.; Okahata, Y.; Sato, T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta, 2001, 1514(1), 51-64.
45. Kim, Y.J.; Chae, S.Y.; Jin, C.H.; Sivasubramanian, M.; Son, S.; Choi, K.Y.; Jo, D.G.; Kim, K.; Chan Kwon, I.; Lee, K.C.; Park, J.H. Ionic complex systems based on hyaluronic acid and pegylated tnf-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. Biomaterials, 2010, 31(34), 9057-9064.
46. Huang, M.; Vitharana, S.N.; Peek, L.J.; Coop, T.; Berkland, C. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules, 2007, 8(5), 1607-1614.
47. Min, K.H.; Park, K.; Kim, Y.S.; Bae, S.M.; Lee, S.; Jo, H.G.; Park, R.W.; Kim, I.S.; Jeong, S.Y.; Kim, K.; Kwon, I.C. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control. Release, 2008, 127(3), 208-218.
48. Zhang, C.; Qineng, P.; Zhang, H. Self-assembly and characterization of paclitaxel-loaded n-octyl-o-sulfate chitosan micellar system. Colloids Surf. B Biointerfaces, 2004, 39(1-2), 69-75.
49. Gref, R.; Rodrigues, J.; Couvreur, P. Polysaccharides grafted with polyesters: novel amphiphilic copolymers for biomedical applications. Macromolecules, 2002, 35(27), 9861-9867.
50. Park, K.; Kim, K.; Kwon, I.C.; Kim, S.K.; Lee, S.; Lee, D.Y.; Byun, Y. Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates. Langmuir, 2004, 20(26), 11726-11731.
51. Choi, K.Y.; Min, K.H.; Na, J.H.; Choi, K.; Kim, K.; Park, J.H.; Kwon, I.C.; Jeong, S.Y. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J. Mater. Chem., 2009, 19(24), 4102-4107.
52. Saravanakumar, G.; Choi, K.Y.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Park, K. Hydrotropic hyaluronic acid conjugates: synthesis, characterization, and implications as a carrier of paclitaxel. Int. J. Pharm., 2010, 394(1-2), 154-161.
53. Lee, H.; Ahn, C.H.; Park, T.G. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol. Biosci., 2009, 9(4), 336-342.
54. Akiyoshi, K.; Kobayashi, S.; Shichibe, S.; Mix, D.; Baudys, M.; Wan Kim, S.; Sunamoto, J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release, 1998, 54(3), 313-320.
55. Oh, E.J.; Park, K.; Kim, K.S.; Kim, J.; Yang, J.A.; Kong, J.H.; Lee, M.Y.; Hoffman, A.S.; Hahn, S.K. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J. Control. Release, 2010, 141(1), 2-12.
56. Kim, K.; Kim, J.H.; Park, H.; Kim, Y.S.; Park, K.; Nam, H.; Lee, S.; Park, J.H.; Park, R.W.; Kim, I.S.; Choi, K.; Kim, S.Y.; Park, K.; Kwon, I.C. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. J. Control. Release, 2010, 146(2), 219-227.
57. Kim, J.H.; Kim, Y.S.; Park, K.; Lee, S.; Nam, H.Y.; Min, K.H.; Jo, H.G.; Park, J.H.; Choi, K.; Jeong, S.Y.; Park, R.W.; Kim, I.S.; Kim, K.; Kwon, I.C. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J. Control. Release, 2008, 127(1), 41-49.
58. Hwang, H.Y.; Kim, I.S.; Kwon, I.C.; Kim, Y.H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J. Control. Release, 2008, 128(1), 23-31.
59. Ayame, H.; Morimoto, N.; Akiyoshi, K. Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug. Chem., 2008, 19(4), 882-890.
60. Ikeda, K.; Okada, T.; Sawada, S.-i.; Akiyoshi, K.; Matsuzaki, K. Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones. FEBS Lett., 2006, 580(28-29), 6587-6595.
61. Sasaki, Y.; Akiyoshi, K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem. Rec., 2010, 10(6), 366-376.
62. Choi, K.Y.; Chung, H.; Min, K.H.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Jeong, S.Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials, 2010, 31(1), 106-114.
63. Choi, K.Y.; Lee, S.; Park, K.; Kim, K.; Park, J.H.; Kwon, I.C.; Jeong, S.Y. Preparation and characterization of hyaluronic acid-based hydrogel nanoparticles. J. Phys. Chem. Solids, 2008, 69(5-6), 1591-1595.
64. Saravanakumar, G.; Min, K.H.; Min, D.S.; Kim, A.Y.; Lee, C.M.; Cho, Y.W.; Lee, S.C.; Kim, K.; Jeong, S.Y.; Park, K.; Park, J.H.; Kwon, I.C. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: Synthesis, characterization, and in vivo biodistribution. J. Control. Release, 2009, 140(3), 210-217.
65. Discher, D.E.; Eisenberg, A. Polymer vesicles. Science, 2002, 297(5583), 967-973.
66. Upadhyay, K.K.; Bhatt, A.N.; Mishra, A.K.; Dwarakanath, B.S.; Jain, S.; Schatz, C.; Le Meins, J.F.; Farooque, A.; Chandraiah, G.; Jain, A.K.; Misra, A.; Lecommandoux, S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly([gamma]-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials, 2010, 31(10), 2882-2892.
67. Upadhyay, K.K.; Bhatt, A.N.; Castro, E.; Mishra, A.K.; Chuttani, K.; Dwarakanath, B.S.; Schatz, C.; Le Meins, J.F.; Misra, A.; Lecommandoux, S. In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes. Macromol. Biosci., 2010, 10(5), 503-512.
68. Upadhyay, K.K.; Meins, J.F.L.; Misra, A.; Voisin, P.; Bouchaud, V.; Ibarboure, E.; Schatz, C.; Lecommandoux, S. Biomimetic doxorubicin loaded polymersomes from hyaluronan-block-poly(γ-benzyl glutamate) copolymers. Biomacromolecules, 2009, 10(10), 2802-2808.
69. Meier, W. Polymer nanocapsules. Chem. Soc. Rev., 2000, 29(5), 295-303.
70. Mora-Huertas, C.E.; Fessi, H.; Elaissari, A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm., 2010, 385(1-2), 113-142.
71. Caruso, F. Hollow capsule processing through colloidal templating and self-assembly. Chemistry, 2000, 6(3), 413-419.
72. Cuomo, F.; Lopez, F.; Miguel, M.G.; Lindman, B. Vesicle-templated layer-by-layer assembly for the production of nanocapsules. Langmuir, 2010, 26(13), 10555-10560.
73. Hu, Y.; Ding, Y.; Ding, D.; Sun, M.; Zhang, L.; Jiang, X.; Yang, C. Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. Biomacromolecules, 2007, 8(4), 1069-1076.
74. Wang, W.; Luo, C.; Shao, S.; Zhou, S. Chitosan hollow nanospheres fabricated from biodegradable poly-d, l-lactide-poly(ethylene glycol) nanoparticle templates. Eur. J. Pharm. Biopharm., 2010, 76(3), 376-383.
75. Yin, Y.; Xu, S.; Chang, D.; Zheng, H.; Li, J.; Liu, X.; Xu, P.; Xiong, F. One-pot synthesis of biopolymeric hollow nanospheres by photocrosslinking. Chem. Commun., 2010, 46(43), 8222-8224.
76. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov., 2005, 4(2), 145-160.
77. Takeuchi, H.; Matsui, Y.; Yamamoto, H.; Kawashima, Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J. Control. Release, 2003, 86(2-3), 235-242.
78. Sihorkar, V.; Vyas, S.P. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J. Pharm. Pharm. Sci., 2001, 4(2), 138-158.
79. Wang, Y.; Tu, S.; Li, R.; Yang, X.; Liu, L.; Zhang, Q. Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior. Nanomedicine, 2010, 6(3), 471-477.
80. Carafa, M.; Marianecci, C.; Annibaldi, V.; Di Stefano, A.; Sozio, P.; Santucci, E. Novel o-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide. Int. J. Pharm., 2006, 325(1-2), 155-162.
81. Liang, G.; Jia-Bi, Z.; Fei, X.; Bin, N. Preparation, characterization and pharmacokinetics of n-palmitoyl chitosan anchored docetaxel liposomes. J. Pharm. Pharmacol., 2007, 59(5), 661-667.
82. Peer, D.; Margalit, R. Loading mitomycin c inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int. J. Cancer, 2004, 108(5), 780-789.
83. Peer, D.; Margalit, R. Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia, 2004, 6(4), 343-353.
84. Fukui, Y.; Fujimoto, K. The preparation of sugar polymer-coated nanocapsules by the layer-by-layer deposition on the liposome. Langmuir, 2009, 25(17), 10020-10025.
85. Guo, C.; Gemeinhart, R.A. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles. Eur. J. Pharm. Biopharm., 2008, 70(2), 597-604.
86. Ravi Kumar, M.N.V.; Bakowsky, U.; Lehr, C.M. Preparation and characterization of cationic plga nanospheres as DNA carriers. Biomaterials, 2004, 25(10), 1771-1777.
87. Yuan, X.; Shah, B.; Kotadia, N.; Li, J.; Gu, H.; Wu, Z. The development and mechanism studies of cationic chitosan-modified biodegradable plga nanoparticles for efficient sirna drug delivery. Pharm. Res., 2010, 27(7), 1285-1295.
88. Tahara, K.; Yamamoto, H.; Hirashima, N.; Kawashima, Y. Chitosan-modified poly(d, l-lactide-co-glycolide) nanospheres for improving sirna delivery and gene-silencing effects. Eur. J. Pharm. Biopharm., 2010, 74(3), 421-426.
89. Yang, R.; Shim, W.S.; Cui, F.D.; Cheng, G.; Han, X.; Jin, Q.R.; Kim, D.D.; Chung, S.J.; Shim, C.K. Enhanced electrostatic interaction between chitosan-modified plga nanoparticle and tumor. Int. J. Pharm., 2009, 371(1-2), 142-147.
90. Yang, R.; Yang, S.G.; Shim, W.S.; Cui, F.; Cheng, G.; Kim, I.W.; Kim, D.D.; Chung, S.J.; Shim, C.K. Lung-specific delivery of paclitaxel by chitosan-modified plga nanoparticles via transient formation of microaggregates. J. Pharm. Sci., 2009, 98(3), 970-984.
91. Chung, Y.I.; Kim, J.C.; Kim, Y.H.; Tae, G.; Lee, S.Y.; Kim, K.; Kwon, I.C. The effect of surface functionalization of plga nanoparticles by heparin-or chitosan-conjugated pluronic on tumor targeting. J. Control. Release, 2010, 143(3), 374-382.
92. Wang, Z.H.; Wang, Z.Y.; Sun, C.S.; Wang, C.Y.; Jiang, T.Y.; Wang, S.L. Trimethylated chitosan-conjugated plga nanoparticles for the delivery of drugs to the brain. Biomaterials, 2010, 31(5), 908-915.
93. Hyung, W.; Ko, H.; Park, J.; Lim, E.; Park, S.B.; Park, Y.J.; Yoon, H.G.; Suh, J.S.; Haam, S.; Huh, Y.M. Novel hyaluronic acid (ha) coated drug carriers (hcdcs) for human breast cancer treatment. Biotechnol. Bioeng., 2008, 99(2), 442-454.
94. Passirani, C.; Barratt, G.; Devissaguet, J.P.; Labarre, D. Long-circulating nanopartides bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm. Res., 1998, 15(7), 1046-1050.
95. Gupta, A.K.; Naregalkar, R.R.; Vaidya, V.D.; Gupta, M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine, 2007, 2(1), 23-39.
96. Cheong, S.J.; Lee, C.M.; Kim, S.L.; Jeong, H.J.; Kim, E.M.; Park, E.H.; Kim, D.W.; Lim, S.T.; Sohn, M.H. Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. Int. J. Pharm., 2009, 372(1-2), 169-176.
97. Qiao, R.; Yang, C.; Gao, M. Superparamagnetic iron oxide nanoparticles: From preparations to in vivo mri applications. J. Mater. Chem., 2009, 19(35), 6274-6293.
98. Tassa, C.; Shaw, S.Y.; Weissleder, R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc. Chem. Res., 2011, 44(10), 842-852.
99. Chen, T.J.; Cheng, T.H.; Chen, C.Y.; Hsu, S.; Cheng, T.L.; Liu, G.C.; Wang, Y.M. Targeted herceptin-dextran iron oxide nanoparticles for noninvasive imaging of her2/neu receptors using mri. J. Biol. Inorg. Chem., 2009, 14(2), 253-260.
100. Jarrett, B.R.; Frendo, M.; Vogan, J.; Louie, A.Y. Size-controlled synthesis of dextran sulfate coated iron oxide nanoparticles for magnetic resonance imaging. Nanotechnology, 2007, 18(3), 035603.
101. Kamat, M.; El-Boubbou, K.; Zhu, D.C.; Lansdell, T.; Lu, X.; Li, W.; Huang, X. Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. Bioconjug. Chem., 2010, 21(11), 2128-2135.
102. Lee, D.-E.; Kim, A.; Saravanakumar, G.; Koo, H.; Kwon, I.; Choi, K.; Park, J.; Kim, K. Hyaluronidase-sensitive spions for mr/optical dual imaging nanoprobes. Macromol. Res., 2011, 19(8), 861-867.
103. Lee, Y.; Lee, H.; Kim, Y.B.; Kim, J.; Hyeon, T.; Park, H.; Messersmith, P.B.; Park, T.G. Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Adv. Mater., 2008, 20(21), 4154-4157.
104. Lee, C.M.; Jeong, H.J.; Kim, S.L.; Kim, E.M.; Kim, D.W.; Lim, S.T.; Jang, K.Y.; Jeong, Y.Y.; Nah, J.W.; Sohn, M.H., Spion-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Int. J. Pharm., 2009, 371(1-2), 163-169.
105. Lee, C.M.; Jang, D.; Kim, J.; Cheong, S.J.; Kim, E.M.; Jeong, M.H.; Kim, S.H.; Kim, D.W.; Lim, S.T.; Sohn, M.H.; Jeong, Y.Y.; Jeong, H.J. Oleyl-chitosan nanoparticles based on a dual probe for optical/mr imaging in vivo. Bioconjug. Chem., 2011, 22(2), 186-192.
106. Ghosh, P.; Han, G.; De, M.; Kim, C.K.; Rotello, V.M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev., 2008, 60(11), 1307-1315.
107. Sun, I.C.; Eun, D.K.; Na, J.H.; Lee, S.; Kim, I.J.; Youn, I.C.; Ko, C.Y.; Kim, H.S.; Lim, D.; Choi, K.; Messersmith, P.B.; Park, T.G.; Kim, S.Y.; Kwon, I.C.; Kim, K.; Ahn, C.H. Heparin-coated gold nanoparticles for liver-specific ct imaging. Chem. Eur. J., 2009, 15(48), 13341-13347.
108. Lee, K.; Lee, H.; Bae, K.H.; Park, T.G. Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells. Biomaterials, 2010, 31(25), 6530-6536.
109. Lee, H.; Lee, K.; Kim, I.K.; Park, T.G. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials, 2008, 29(35), 4709-4718.
110. Sun, I.C.; Eun, D.K.; Koo, H.; Ko, C.Y.; Kim, H.S.; Yi, D.K.; Choi, K.; Kwon, I.C.; Kim, K.; Ahn, C.H. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew. Chem. Int. Ed., 2011, 50(40), 9348-9351.
111. Lee, M.Y.; Park, S.J.; Park, K.; Kim, K.S.; Lee, H.; Hahn, S.K. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/ sirna/pei/ha nanocomplex. ACS Nano, 2011, 5(8), 6138-6147.
112. Bhumkar, D.; Joshi, H.; Sastry, M.; Pokharkar, V. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res., 2007, 24(8), 1415-1426.
113. Yu, W.W.; Chang, E.; Drezek, R.; Colvin, V.L. Water-soluble quantum dots for biomedical applications. Biochem. Biophys. Res. Commun., 2006, 348(3), 781-786.
114. Hasegawa, U.; Nomura, S.M.; Kaul, S.C.; Hirano, T.; Akiyoshi, K. Nanogel-quantum dot hybrid nanoparticles for live cell imaging. Biochem. Biophys. Res. Commun., 2005, 331(4), 917-921.
115. Wilson, R.; Spiller, D.G.; Beckett, A.; Prior, I.A.; Sée, V. Highly stable dextran-coated quantum dots for biomolecular detection and cellular imaging. Chem. Mater., 2010, 22(23), 6361-6369.
116. Bhang, S.H.; Won, N.; Lee, T.J.; Jin, H.; Nam, J.; Park, J.; Chung, H.; Park, H.S.; Sung, Y.E.; Hahn, S.K.; Kim, B.S.; Kim, S. Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging. ACS Nano, 2009, 3(6), 1389-1398.
117. Kim, K.S.; Hur, W.; Park, S.J.; Hong, S.W.; Choi, J.E.; Goh, E.J.; Yoon, S.K.; Hahn, S.K. Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano, 2010, 4(6), 3005-3014.
118. Lin, Y.; Zhang, L.; Yao, W.; Qian, H.; Ding, D.; Wu, W.; Jiang, X. Water-soluble chitosan-quantum dot hybrid nanospheres toward bioimaging and biolabeling. ACS Appl. Mater. Interfaces, 2011, 3(4), 995-1002.
119. Tan, W.B.; Jiang, S.; Zhang, Y. Quantum-dot based nanoparticles for targeted silencing of her2/neu gene via rna interference. Biomaterials, 2007, 28(8), 1565-1571.
120. Zahr, A.S.; Davis, C.A.; Pishko, M.V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir, 2006, 22(19), 8178-8185.
121. Owens Iii, D.E.; Peppas, N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm., 2006, 307(1), 93-102.
122. Otsuka, H.; Nagasaki, Y.; Kataoka, K. Pegylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev., 2003, 55(3), 403-419.
123. Harris, J.M.; Chess, R.B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov., 2003, 2(3), 214-221.
124. Qu, G.; Yao, Z.; Zhang, C.; Wu, X.; Ping, Q. Peg conjugated n-octyl-o-sulfate chitosan micelles for delivery of paclitaxel: In vitro characterization and in vivo evaluation. Eur. J. Pharm. Sci., 2009, 37(2), 98-105.
125. Prego, C.; Torres, D.; Fernandez-Megia, E.; Novoa-Carballal, R.; Quiñoá, E.; Alonso, M.J. Chitosan-peg nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J. Control. Release, 2006, 111(3), 299-308.
126. Zhang, X.; Zhang, H.; Wu, Z.; Wang, Z.; Niu, H.; Li, C. Nasal absorption enhancement of insulin using peg-grafted chitosan nanoparticles. Eur. J. Pharm. Biopharm., 2008, 68(3), 526-534.
127. Choi, K.Y.; Min, K.H.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Choi, K.; Jeong, S.Y. Pegylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials, 2011, 32(7), 1880-1889.
128. Bae, Y.H.; Yin, H. Stability issues of polymeric micelles. J. Control. Release, 2008, 131(1), 2-4.
129. Savić, R.; Azzam, T.; Eisenberg, A.; Maysinger, D. Assessment of the integrity of poly(caprolactone)-b-poly(ethylene oxide) micelles under biological conditions. A fluorogenic-based approach. Langmuir, 2006, 22(8), 3570-3578.
130. O'Reilly, R.K.; Hawker, C.J.; Wooley, K.L. Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem. Soc. Rev., 2006, 35(11), 1068-1083.
131. Li, Y.L.; Zhu, L.; Liu, Z.; Cheng, R.; Meng, F.; Cui, J.H.; Ji, S.J.; Zhong, Z. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew. Chem. Int. Ed., 2009, 48(52), 9914-9918.
132. Sugawara, A.; Yamane, S.; Akiyoshi, K. Nanogel-templated mineralization: polymer-calcium phosphate hybrid nanomaterials. Macromol. Rapid Commun., 2006, 27(6), 441-446.
133. Lee, H.J.; Kim, S.E.; Kwon, I.K.; Park, C.; Kim, C.; Yang, J.; Lee, S.C. Spatially mineralized self-assembled polymeric nanocarriers with enhanced robustness and controlled drug-releasing property. Chem. Commun. (Camb.), 2010, 46(3), 377-379.
134. Han, S.Y.; Han, H.S.; Lee, S.C.; Kang, Y.M.; Kim, I.S.; Park, J.H. Mineralized hyaluronic acid nanoparticles as a robust drug carrier. J. Mater. Chem., 2011, 21(22), 7996-8001.
135. You, J.; Li, X.; Cui, F.d.; Du, Y.Z.; Yuan, H.; Hu, F.Q. Folate-conjugated polymer micelles for active targeting to cancer cells: Preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology, 2008, 19(4), 045102.
136. Dufes, C.; Muller, J.M.; Couet, W.; Olivier, J.C.; Uchegbu, I.; Schätzlein, A. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm. Res., 2004, 21(1), 101-107.
137. Han, H.D.; Mangala, L.S.; Lee, J.W.; Shahzad, M.M.K.; Kim, H.S.; Shen, D.; Nam, E.J.; Mora, E.M.; Stone, R.L.; Lu, C.; Lee, S.J.; Roh, J.W.; Nick, A.M.; Lopez-Berestein, G.; Sood, A.K. Targeted gene silencing using rgd-labeled chitosan nanoparticles. Clin. Cancer Res., 2010, 16(15), 3910-3922.
138. Yang, S.J.; Lin, F.H.; Tsai, H.M.; Lin, C.F.; Chin, H.C.; Wong, J.M.; Shieh, M.J. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials, 2011, 32(8), 2174-2182.
139. Kim, S.; Park, K.M.; Ko, J.Y.; Kwon, I.C.; Cho, H.G.; Kang, D.; Yu, I.T.; Kim, K.; Na, K. Minimalism in fabrication of self-organized nanogels holding both anti-cancer drug and targeting moiety. Colloids Surf. B Biointerfaces, 2008, 63(1), 55-63.
140. Bae, B.C.; Na, K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials, 2010, 31(24), 6325-6335.
141. Wang, X.; Li, J.; Wang, Y.; Cho, K.J.; Kim, G.; Gjyrezi, A.; Koenig, L.; Giannakakou, P.; Shin, H.J.C.; Tighiouart, M.; Nie, S.; Chen, Z.; Shin, D.M. Hft-t, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano, 2009, 3(10), 3165-3174.
142. Park, J.H.; Saravanakumar, G.; Kim, K.; Kwon, I.C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev., 2010, 62(1), 28-41.
143. Fan, L.; Wu, H.; Zhang, H.; Li, F.; Yang, T.H.; Gu, C.H.; Yang, Q. Novel super ph-sensitive nanoparticles responsive to tumor extracellular ph. Carbohydr. Polym., 2008, 73(3), 390-400.
144. Son, Y.J.; Jang, J.S.; Cho, Y.W.; Chung, H.; Park, R.W.; Kwon, I.C.; Kim, I.S.; Park, J.Y.; Seo, S.B.; Park, C.R.; Jeong, S.Y. Biodistribution and antitumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by epr effect. J. Control. Release, 2003, 91(1-2), 135-145.
145. Lin, Y.H.; Chang, C.H.; Wu, Y.S.; Hsu, Y.M.; Chiou, S.F.; Chen, Y.J. Development of ph-responsive chitosan/heparin nanoparticles for stomach-specific anti-helicobacter pylori therapy. Biomaterials, 2009, 30(19), 3332-3342.